At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Examine the Effects of Novel E-cigarette Constituents and Determining Appropriate Concentrations Among Adults
In Brief
A clinical study evaluating E-liquid coolant (WS-3, 0.05%), E-liquid coolant (WS-3, 0.1%), and 14 other interventions for E-Cig Use. Completed, enrolled 31 participants across 1 site.
Detailed Summary
This pilot sensory experiment will examine cooling from comparable concentrations of WS-3 and menthol to determine appropriate concentrations to use in the main study.
Study Details
Timeline
Interventions
Adult users of e-cigarette will be exposed to five e-liquid coolants WS-3: 0.05%.
Adult users of e-cigarette will be exposed to five e-liquid coolants WS-3: 0.1%.
Adult users of e-cigarette will be exposed to five e-liquid coolants WS-3: 0.5%.
Adult users of e-cigarette will be exposed to five e-liquid coolants WS-3: 1.0%.
Adult users of e-cigarette will be exposed to five e-liquid coolants WS-3: 2.0%.
Adult users of e-cigarette will be exposed to five e-liquid coolants menthol: 0.05%.
Adult users of e-cigarette will be exposed to five e-liquid coolants menthol: 0.1%.
Adult users of e-cigarette will be exposed to five e-liquid coolants menthol: 0.5%.
Adult users of e-cigarette will be exposed to five e-liquid coolants menthol: 1.0%.
Adult users of e-cigarette will be exposed to five e-liquid coolants menthol: 2.0%.
Adult users of e-cigarette will be exposed to six e-liquid coolants WS-23: 0.05%.
Adult users of e-cigarette will be exposed to six e-liquid coolants WS-23: 0.1%.
Adult users of e-cigarette will be exposed to six e-liquid coolants WS-23: 0.5%.
Adult users of e-cigarette will be exposed to six e-liquid coolants WS-23: 1.0%.
Adult users of e-cigarette will be exposed to six e-liquid coolants WS-23: 2.0%.
Adult users of e-cigarette will be exposed to six e-liquid coolants WS-23: 4.0%.